NCT00225719View on ClinicalTrials.gov

Effect of rHDL on Atherosclerosis - Safety and Efficacy: THE ERASE TRIAL

PHASE2CompletedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

July 31, 2005

Conditions

Acute Coronary Syndromes

Interventions

DRUG

rHDL

Trial Locations (1)

H1T 1C8

Montreal Heart Institute, Montreal

All Listed Sponsors

lead

CSL Limited

INDUSTRY

NCT00225719 - Effect of rHDL on Atherosclerosis - Safety and Efficacy: THE ERASE TRIAL | Biotech Hunter | Biotech Hunter